Stiris Research Inc.

MHI Introduces Small-batch Blister Machine

Designed as a reliable, cost-effective solution for development stages, stability testing and initial small-batch production.

02.02.23

Breaking News | Facilities | Industry News

Lilly to Invest $450M at Manufacturing Site in Research Triangle Park

Expansion includes additional parenteral filling, device assembly and packaging capacity to support an increased demand for Lilly's incretin products.

01.30.23

Breaking News | Drug Development | Drug Discovery | Industry News

Rentschler Biopharma to Support Albert Einstein Discovery Center

Donates 50,000 Euros to support the creation of the discovery and activity center in Ulm.

09.22.21

Breaking News | Industry News | Laboratory Testing

Metrion Biosciences Expands into New Cambridge HQ

New 12,000 sq. ft. Cambridge, UK premises more than doubles lab space.

09.22.21

Biologics, Proteins, Vaccines | Breaking News | Clinical Trials

Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany

Covers the combination of DHODH inhibitors and nucleoside analogues to treat viral infections, including Covid-19.

09.22.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

CuriRx Launches CuriLytics Platform for Biotherapeutic Development

To provide CMC analytical services to support complex biotherapeutic development using high resolution mass spectrometry.

09.21.21

Biologics, Proteins, Vaccines | Reader Showcase

Thermo Fisher Launches Gibco AAV Production System

Aims to address the need to make adeno-associated virus (AAV) production more efficient and scalable.

09.20.21

Breaking News | Promotions & Moves

Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer

Schetter has a proven track record across the entire biopharmaceutical value chain.

09.20.21

Breaking News | Collaborations & Alliances | Industry News

Asychem Partners with LaNova Medicines

Will provide one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration.

09.16.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Vaccine Developer Intravacc Adopts Hybrid Business Model

Aims to spur further innovation and sustainable growth over the next five years.

09.16.21

Breaking News | Clinical Trials

Syneos Health Acquires Clinical Trial Recruitment and Retention Company StudyKIK

Accelerates product development by better connecting patients, sites and communities.

09.15.21

Breaking News | Industry News

U.S. Govt. to Purchase Additional Doses of REGEN-COV Antibody Cocktail

Will supply an additional 1.4 million 1,200 mg doses of REGEN-COV to the U.S. government by January 31, 2022.

09.15.21

Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology

Novo Nordisk Launches Foundation Center for Genomic Mechanisms of Disease

Initiative, together with the Broad Institute of MIT and Harvard, aims to accelerate efforts to mine genetic data for insights into disease mechanisms.

09.15.21

Breaking News | Industry News

U.S. Govt. Purchases Additional Doses of Lilly's Antibody Therapies for COVID

Will supply 388,000 doses of etesevimab to complement doses of bamlanivimab previously purchased, with approximately 200,000 doses expected to ship 3Q21.

09.15.21

Breaking News | Industry News | Promotions & Moves

Aurion Biotech Makes Strategic Investments in Manufacturing

Appoints Tim Largen as VP of manufacturing to drive cell therapy production strategy and direct collaborations with leading CDMOs.

09.14.21

Breaking News | Collaborations & Alliances | Industry News

Lakes BioScience Signs Agreement with Cytvia

Initiates the implementation of innovative workflows at Lakes BioScience’s factory in Cumbria.

09.14.21

Drug Development | Laboratory Testing

Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies

The importance of reagent quality control, especially endotoxin testing, during CGT development and the selection of reagents and suppliers to ensure safety.

Garrett Perry, Technical Services Specialists at Teknova 09.14.21

Breaking News | CRO News | Drug Discovery | Industry News | Preclinical Outsourcing

Frontage Expands Early Drug Discovery Services

Acquires majority stake in Wuhan Heyan Biomedical Technology.

09.14.21

Breaking News | Promotions & Moves

Eloxx Pharmaceutical Appoints Ali Hairiri as Chief Medical Officer

Hairiri will oversee clinical development efforts for the company’s pipeline of therapies to treat rare diseases.

09.10.21

Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News

Boehringer Ingelheim, Twist Bioscience Enter Antibody Discovery Collaboration

Research collaboration covers multiple antibody research programs.

09.10.21

Antimicrobial Resistance ‘Arms Race’ Realizes Advancements as Post-Antibiotic Era Ensues

Emerging innovations and non-antibiotic approaches to address urgent need to control infectious diseases, including multiple-drug resistant ‘super-bugs’.

Merilee Kern, MBA, Brand Analyst, Strategist and Futurist, and Forbes Business Council Member 09.09.21

Clinical Trials

The Future of Clinical Trials

Dr. Greg Licholai of ICON plc on key market trends, the future of clinical trials and the acquisition of PRA.

Kristin Brooks, Managing Editor 09.09.21

Trust, but Verify

Or, R.I.P, CoA.

Emil W. Ciurczak, DoraMaxx Consulting 09.09.21

Let’s Get Genuine

LinkedIn sales pitches are going away in favor of being real.

David G. Jensen, Contributing Editor 09.09.21

APIs | Clinical Trial Materials

Outsourcing the Manufacture of Clinical Trial APIs

What to consider when deciding to partner with a CDMO for manufacturing.

Josh Hoerner, General Manager, Purisys 09.09.21

Drug Delivery

Inhaled Drug Delivery Trends

Designing dry powder devices for inhaled drugs.

Andreas M. Meliniotis, Director of Device Development, Vectura 09.09.21

Clinical Trial Materials | Clinical Trials | Supply Chain

Clinical Trial Kitting

Overcome the challenges to make every sample count.

Claudia Berrón and Arbi Harootoonian, Avantor 09.09.21

Analytical Services | Bioanalytical Services

Putting Laboratory Suppliers to the Test in the COVID Era – and Beyond

Build resiliency into analytical methods through careful consideration of chromatography partners.

Hazel Dickson, PhD, Marketing Manager, Chemistry Group, Waters Corporation 09.09.21

Breaking News | Chemistry | Industry News | Laboratory Testing

Sterling Pharma Solutions Creates Flow Chemistry CoE

Completes initial phase of investment at its site in Dudley, UK for research into commercial applications of continuous flow chemistry.

09.09.21

Breaking News | Drug Discovery | Industry News | Laboratory Testing

Frontage Shanghai Acquires Wuhan Heyan Biomedical

Provides target based in vitro pharmacodynamic screening and early pharmacological pharmacodynamic evaluation services.

09.09.21

Breaking News | Industry News | Information Technology

Medrio and Phastar Partner to Leverage Metadata for Advanced Data Visualization

Aim to monitor compliance, patient burden and any anomalies that may ultimately impact the interpretation of results.

09.08.21

cGMP Manufacture | Drug Development | QA/QC

Three Tips for Navigating Post-Approval Pharmacovigilance

Seamlessly transition from regulatory reporting to post-approval safety surveillance in today’s market.

Emmanuel Belabe, Associate Vice President, Safety Product Management, ArisGlobal, Nina Patel Lahanis, Associate Vice President, Safety Science, EVERSANA 09.08.21

Breaking News | Clinical Trials | Collaborations & Alliances

LTO Network, Sphereon, Triall to Deliver COVID-19 Trials Anchored to Blockchain Tech

Will anchor research data to the blockchain, securing the integrity and security of clinical trial data.

09.07.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

CEVEC, UCB Ink AAV Mfg. Technology Agreement

UCB will use of CEVEC’s ELEVECTA AAV manufacturing technology in gene therapy.

09.07.21

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

Adaptimmune, Genentech Enter Strategic R&D Collaboration

To research, develop, and commercialize cancer-targeted Allogeneic T-cell therapies.

09.07.21

Clinical Trials | Information Technology

Clinical Trials are Transforming Right Before Our Eyes

Decentralized clinical trials, an innovation just a short time ago, are now mainstream.

Kristin Brooks, Managing Editor, Contract Pharma 09.03.21

Promotions & Moves

Avacta Names Fiona McLaughlin as Therapeutics Division CSO

Dr. McLaughlin is a highly experienced oncology drug developer, bringing over 25 years of experience in research and translational drug development.

09.02.21

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

Secarna, Evotec Expand Strategic Antisense Discovery Pact

To discover, research and develop programs leveraging Secarna’s antisense oligonucleotide expertise with Evotec’s discovery and development capabilities.

09.02.21

Bachem reports excellent results for the first half-year 2021

Sales of CHF 500 million are now expected for the year 2021.

FairJourney Biologics Expands into New Facilities

Newly purpose-built research center in Porto, Portugal supports rapid expansion.

09.01.21

Breaking News | Drug Development | Industry News

Innovent Biologics, Bolt Biotherapeutics Enter Immuno-oncology Alliance

Will leverage Innovent's therapeutic antibody portfolio and discovery capability against undisclosed oncology targets in combination with Bolt's ISAC technology

08.27.21

EOC Pharma and Chime Biologics Extend Partnership

For the CMC development of EOC202, a recombinant LAG-3 protein for cancer immunotherapy.

08.26.21

Breaking News | Collaborations & Alliances

Cryoport and Mitsubishi Logistics Corporation Partner

Will work together to bring temperature-controlled supply chain solutions to Asia-Pacific.

08.25.21

Breaking News | Collaborations & Alliances | R&D

Roche, Shape Therapeutics Enter Strategic Gene Therapy Collaboration

ShapeTX will apply its RNA editing platform and leverage its AAVid technology platform for the development of gene therapy for various diseases.

08.25.21

Breaking News | Collaborations & Alliances

Lilly, Lycia Therapeutics Enter Multi-Year R&D Alliance

Will leverage Lycia's LYTAC protein degradation technology to discover, develop and commercialize targeted therapeutics in immunology and pain.

08.25.21

Bachem and Novo Nordisk Redesign SPPS for Green Chemistry

Replacing gold standard solvents to provide a greener alternative.

APIs

Propofol – A Bachem Success Story

The COVID-19 pandemic has rapidly expanded awareness of the API Propofol, produced by Bachem in Vionnaz.

McMaster, Sartorius Enter Biomanufacturing Partnership

Team up to advance biomanufacturing processes with next-gen tech.

08.23.21

Bio News | Breaking News | Industry News

Pfizer to Acquire Trillium Therapeutics for $2.3B

Strengthens oncology portfolio with addition of next-generation, investigational immuno-therapeutics for hematological malignancies.

08.23.21

Breaking News | Industry News | Promotions & Moves

J&J CEO Alex Gorsky to Step Aside

Company will transition the CEO role to Joaquin Duato at the start of 2022.

08.23.21

Bioanalytical Services

Ensuring Equitable Access to Next-generation Sequencing in Oncology

Recent advances in sequencing techniques have transformed cancer treatment.

Gang Song, Ph.D., CEO & Co-Founder, Pillar Biosciences 08.20.21

Bio News | Breaking News | Industry News

PBS Biotech Scales-Up Manufacturing Solutions for Cell Therapies

Raises $10 million to grow its product offerings and capabilities.

08.20.21

Breaking News | Facilities | Industry News

Sai Life Sciences Opens New Biology Facility in Hyperbad, India

Positions itself as a differentiated player in Discovery Biology.

08.19.21

Breaking News | CRO News | Industry News

BioAgilytix Acquires MicroConstants

The business will complement BioAgilytix's contract research services for the pharmaceutical and biotech industry.

08.19.21

APIs | Breaking News | Facilities | Industry News

Curia to Expand U.S. Commercial Manufacturing Capability

Roughly $35 million will be invested to expand manufacturing and product-handling solutions for complex small molecules.

08.19.21

Drug Development | Drug Discovery

Antimicrobial Resistance ‘Arms Race’ Realizes Advancements as Post-Antibiotic Era Ensues

Emerging innovations and non-antibiotic approaches to address urgent need to control infectious diseases, including multiple-drug resistant ‘super-bugs’

Merilee Kern 08.18.21

Breaking News | Drug Development | Drug Discovery | Industry News | Laboratory Testing

Astellas, LabCentral Partner to Help Emerging Biotechs Accelerate Research

Future Innovator Prize offers one-year use of LabCentral's state-of-the-art lab facility in Cambridge, MA and access to Astellas' R&D capabilities.

08.18.21

Breaking News | Industry News | Promotions & Moves

Lilly Forms Neuroscience and Immunology BUs

Makes executive leadership changes.

08.17.21

Clinical Trials | Information Technology

Enabling Decentralized Clinical Trials through Digital Transformation

Adopting a strategy of “bringing the technology to the data.”

Temitope Keyes, Executive Director, Business Development at Cmed Technology 08.17.21

Breaking News | Collaborations & Alliances | Drug Development

Cytocom to Fund Research and Lab Facilities at the La Jolla Institute for Immunology

The research will support the development of potential treatments of cancer, infectious, autoimmune & chronic inflammatory diseases.

08.13.21

Clinical Trials | Cold Chain Management | Logistics

Flexible Ultracold Chain Critical to Decentralized Clinical Trials

Addressing barriers to further grow and accelerate the adoption of patient-focused DCTs.

Timothy Root, Marketing Director, Stirling Ultracold 08.12.21

Biologics, Proteins, Vaccines | Breaking News | Promotions & Moves

Discovery Life Sciences Appoints Cell & Gene Therapy CTO

Dr. Clarke will work to further establish the company as a global leader in cell and gene therapy materials and analytical services.

08.12.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer

Lonza, Sheba Medical Center Leverage Cocoon Platform for Cell Therapy

Customizable, patient-scale cell therapy platform aims to streamline manufacturing to improve process efficiency and reliability.

08.12.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Aldevron, Ginkgo Bioworks Partner on mRNA Vax Mfg. Breakthrough

Achieved improvements in manufacturing yield of vaccinia capping enzyme (VCE), a component often required to produce mRNA therapies and vaccines.

08.11.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Lumen Bioscience, Google Partner to Apply ML to Biologics Manufacturing

Aims to double biomanufacturing productivity.

08.11.21

Breaking News | R&D

Amgen, USC Provide Researchers Access to Thermo Scientific Cryo-EMs

Access to Krios and Glacios microscopes allows researchers from both institutions to combine resources to bring more speed and power to their research.

08.10.21

cGMP Manufacture | Drug Development | Promotions & Moves

Syngene Adds Senior Leadership in the U.S.

Alex Del Priore appointed Senior Vice President, Manufacturing Services, and Alan Collis appointed Vice President, Integrated Drug Discovery Services.

08.06.21

Clinical Trials | Information Technology

Leveraging Clinical Trial Outcomes Through Medication Adherence

Addressing adherence and trial failure, the problem with traditional methods, and the smart way to monitor adherence.

Bernard Vrijens, CEO & Scientific Lead, AARDEX Group 08.05.21

Breaking News | Industry News | Packaging & Tracking

SiO2 Receives $64M Contract from US Government

Supports additional infrastructure of the company's primary packaging containment system platform for storing vaccines and therapeutics.

08.05.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Amgen Investing $550M in New Biomanufacturing Facility

Will create 355 new jobs at Holly Springs, NC site.

08.05.21

Breaking News | Financial Reports

Amgen's 2Q Results

Product sales up 3% in the quarter while earnings were impacted by $1.5 billion in acquired in-process R&D.

08.04.21

Breaking News | Financial Reports

BMS 2Q Revenues up 16%

Top sellers Revlimid, Eliquis and Opdivo drive growth while established brands were down 64%.

07.30.21

Breaking News | Facilities | Industry News

Regeneron Investing $1.8B in Tarrytown, NY Campus

New York's largest biotech company creating an additional 1,000 jobs over five years.

07.29.21

Breaking News | Facilities | Industry News

Nexus Pharmaceuticals Opens State-of-the-Art Manufacturing Facility

Phase I investment of $100 million supports a new three-story manufacturing facility.

07.29.21

Breaking News | Facilities | Industry News

Celanese Opens Pharma Drug Delivery Feasibility Lab

State-of-the-art R&D lab at Florence, KY site expands technical feasibility capabilities for long-acting delivery of small molecules, biologics and nucleotides.

07.29.21

Breaking News | Industry News | Promotions & Moves

Sterling Pharma Solutions Appoints Ian Baxendale to Lead Dudley, UK Site

Baxendale has over 20 years of academic and industrial experience within organic synthesis.

07.29.21

Breaking News | Industry News

Amgen to Acquire Teneobio for $900M

Includes Teneobio's bispecific and multispecific antibody technologies, heavy-chain only platform and T-cell engager platform.

07.28.21

Breaking News | Clinical Trials | Drug Development | Industry News | Information Technology

Almac, THREAD to Integrate Technologies for Clinical Trials

Integrating technology platforms aims to provide sponsors and CROs with a full range of tools designed to reduce the risk of trial delays.

07.28.21

Promotions & Moves

ImmunoGenesis Opens Research Lab, Adds Key Roles

To support the expansion of the company's recently licensed key development assets, clinical and business development activities.

07.28.21

Breaking News | Industry News | Laboratory Testing

Cerba Research Wins NIH Contract for Central Lab Services

To provide clinical lab screening and safety testing for NIAID-supported clinical trials in the area of infectious disease.

07.28.21

Laboratory Testing | Reader Showcase

Pall Launches Minimate EVO Filtration System

Designed to allow high productivity, reproducibility, and simple control compared to stirred-cell technologies.

07.27.21

Biologics, Proteins, Vaccines | Drug Development

AAV-Mediated Gene Therapy: Quantifying Viral Titer and Integrity

Droplet Digital PCR offers precise potency data, critical for the proper dosing of gene therapies.

Mark White and Marwan Alsarraj , Digital Biology Group at Bio-Rad 07.27.21

Breaking News | R&D

Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer

The appointment forms part of the company’s growth strategy for 2021 and 2022, with a focus on the USA, EU and Japan.

07.26.21

Breaking News | CRO News | Industry News

Calyx Expands US Presence in Response to Growing Demand

RTP-based US headquarters established to meet pharmaceutical companies’ and CROs’ increasing needs for e-clinical and regulatory solutions.

07.22.21

Bioanalytical Services | Biologics, Proteins, Vaccines | Filtration & Purification | QA/QC | Reader Showcase

MOBILion Launches MOBIE HRIM for Biotherapeutic Drug Development

Designed to address characterization challenges during biopharmaceutical drug development and quality monitoring.

07.21.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Intravacc's Inactivated Polio Vaccine Out-licensed to Sinovac

Sinovac's Eupolio vaccine (sIPV) receives market authorization from the NMPA in China.

07.20.21

Clinical Trials | CRO News | Information Technology | Reader Showcase

Quanticate Launches Updated Remote Source Data Verification Platform

Cloud-based application allows verification of multiple clinical research sites’ source data to be completed remotely by specialist team at centralized location

07.19.21

Breaking News | Clinical Trials | Industry News | Information Technology

Calyx Opens U.S. HQ Near Research Triangle Park

RTP-based headquarters established to meet growing needs for eClinical and regulatory services.

07.19.21

Bayer

...

07.16.21

Breaking News | CRO News | Facilities | Industry News

CRO Charnwood Molecular Expands Capabilities

$75m construction project in Loughborough creates flexible facility for the growing CRO.

07.16.21

Clinical Trials | Information Technology | Reader Showcase

Almac Offers Expedited IRT Solutions for COVID-19 Trials

Launches the expedited deployment and support of multiple Interactive Response Technology (IRT) solutions in support of COVID-19 treatments

07.16.21

Analytical Services | Supply Chain

Drug Product Safety and Security

Is it even possible in an elongated supply chain?

Emil Ciurczak, President, Doramaxx Consulting 07.16.21

Breaking News | Clinical Trials | Industry News | Information Technology

Medable Opens EMEA HQ in Dublin

Expands European presence to grow market for decentralized clinical trials.

07.15.21

APIs | Breaking News | cGMP Manufacture | Industry News

MediPharm Labs Receives Canadian GMP Pharmaceutical DEL

License can be used for manufacturing, testing and sale of APIs and pharmaceutical drug products containing cannabis.

07.15.21

Batavia Manufactures IAVI’s Lassa Fever Vax Candidate

Uses innovative 'scale-X' bioreactor to support Phase I clinical trials.

07.14.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Curia to Acquire US-based LakePharma

Expanding end-to-end R&D capabilities and scale for biologics.

07.14.21

Leading Teams in a Changing Clinical Research Environment

...

07.13.21

Building Relationships with Clinical Research Sites

...

07.13.21

Curia to Acquire Integrity Bio

Expands biologic formulation and fill-finish capabilities.

07.13.21

Breaking News | Industry News

AMRI Becomes Curia

New brand reinforces ongoing expansion of expertise, capabilities and contributions to health care.

07.12.21

Breaking News | Industry News

Sequanta, Mission Bio Enter Strategic Pact

Provides high-quality single-cell sequence services using Mission Bio's products to customers in mainland China.

07.09.21

Nanotechnology & Medtech: A New Frontier

Three reasons why U.S. medtech companies go overseas for nanotechnology research.

Rachel Shelly, Head of Medical Technologies, IDA Ireland 07.09.21

APIs | Breaking News | GMPs/GCPs | Industry News | QA/QC

Purisys Obtains Two Global ISO Certifications

Now certified for ISO 17025 for Testing and Calibration Laboratories and ISO 17034 for Reference Material Producers.

07.08.21

Biologics, Proteins, Vaccines | cGMP Manufacture

Can mRNA Facilities Really be Flexible?

Four key questions to accommodate growth and expansion.

Jeff Heil, PE , Novel Therapy SME, DPS Group Global 07.08.21

Breaking News | Promotions & Moves

Thermo Fisher Names New Chief Medical Officer

Alan Sachs will assume the newly established role.

07.07.21

Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology

SRI, Sanofi Enter Drug Discovery Collaboration

Will leverage SynFini, SRI’s artificial intelligence and automation platform to accelerate development of small-molecule drug targets.

07.07.21

Collaborations & Alliances | Drug Development

Y-Biologics, Pierre Fabre Enter Immuno-oncology Alliance

Aims to develop and commercialize a family of human antibodies to inhibit the growth of tumor cells.

07.07.21

Mimetas, Roche to Develop Human Disease Models for Drug Development

Will focus on tailor-made phenotypic models for IBD and HBV.

07.06.21

BioMed X Expands Collaboration with Merck

Launches a new joint research program in oncology.

07.06.21

Breaking News | Promotions & Moves

Avid Bioservices Appoints Esther M. Alegria to Board

Former SVP of global manufacturing at Biogen bring nearly 30 years of biopharmaceutical industry experience.

07.02.21

Bio News | Breaking News | Collaborations & Alliances | Industry News

Aragen Expands Discovery Research Agreement with Boehringer Ingelheim

Aims to accelerate the discovery pipeline of Boehringer Ingelheim.

07.01.21

Breaking News | Collaborations & Alliances | Industry News

Innovent Biologics Signs License Agreement with Synaffix

Synaffix will provide proprietary ADC technologies to enable Innovent to rapidly progress one of its antibodies as a best-in-class ADC candidate.

07.01.21

APIs | Breaking News | Facilities | Industry News

Almac Expands Crystallization Capabilities

A new Empyrean X-ray powder diffractometer is part of the investment.

07.01.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Sanofi Launches Dedicated mRNA Vaccines CoE

Approximately €400million investment annually aims to accelerate end-to-end R&D of next-generation vaccines.

06.30.21

eTheRNA, Quantoom Collaborate to Develop Novel RNA Production System

Aims to develop an RNA production system for both research and GMP-grade material.

06.29.21

Breaking News | Clinical Trials | Collaborations & Alliances | Industry News | Information Technology

CMIC and Lokavant Partner to Deploy Clinical Trial Intelligence Platform

Enter first phase of multi-year partnership to deploy predictive analytics platform for monitoring and management of clinical trials in Asia-Pacific.

06.29.21

Formulation Development

Tryp Therapeutics Partners with Alcami for Proprietary Formulations

The agreement represents another step toward the proprietary manufacturing, formulation, and delivery of products for Tryp’s PFNTM program.

Clinical Trials | Information Technology

The Power and Promise of Decentralized Trials

Clinical researchers turned to a range of digital solutions to address the effects of the COVID-19 pandemic on trials.

Derk Arts, CEO, Castor 06.25.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Genezen Breaks Ground on cGMP Lentiviral Vector Production Facility

First phase will see the construction of a 25,000 square feet site including a process development lab expansion.

06.25.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Process Development

Catalent to Acquire RheinCell Therapeutics

Strengthens path towards industrialization of induced pluripotent stem cell-based therapies.

06.25.21

AbCellera to Build Antibody Manufacturing Facility in Canada

130,000-square-foot Vancouver facility aims to accelerate the development of antibody-based therapies for an array of medical conditions.

06.23.21

Breaking News | Industry News | Preclinical Outsourcing

Vectura, Incannex Enter Preclinical Services Agreement

Vectura to provide development services for IHL-216A, Incannex’s inhaled drug product for the treatment of traumatic brain injury.

06.22.21

Breaking News | Collaborations & Alliances

Iksuda, LegoChem Expand ADC Alliance

Grants Iksuda access to LegoChem's next generation ADC platform for up to six targets.

06.22.21

Breaking News | Clinical Trials | CRO News

Syneos Expands Decentralized Trial Capabilities

Aims to accelerate decentralized clinical trial delivery through collaboration with site sponsors.

06.22.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Danaher To Acquire Aldevron for $9.6B

Aldevron will operate as a standalone operating company and brand within Danaher's Life Sciences segment.

06.21.21

Breaking News | Facilities | Formulation Development | Industry News

Coriolis Pharma Expands ATMP Development Facilities

Construction of new facilities for ATMP formulation development up to biosafety level S2 are in progress and operations are expected to start by 4Q21.

06.21.21

Breaking News | Collaborations & Alliances | Drug Development

Jacobio Earns $20M AbbVie Milestone

Initiates Phase 1/2a trial of SHP2 inhibitor JAB-3312 in combination with PD-1 antibody Pembrolizumab and MEK inhibitor Binimetinib.

06.18.21

Breaking News | Industry News | Laboratory Testing

Solvias Acquires Chemic Labs

Establishes U.S. lab presence and expands testing services.

06.18.21

Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Sanofi Invests $425M in Flu Vaccine Manufacturing Facility

Newly licensed U.S. manufacturing facility to increase availability of Fluzone High-Dose Quadrivalent.

06.17.21

Breaking News | Facilities

Thermo Scientific Upgrades Ultra-Low Temperature Freezers

The TSX Series ULT Freezers reliably preserve stored materials in an environmentally and user-friendly design.

06.16.21

Breaking News | Collaborations & Alliances | Drug Development | Formulation Development

Lumen Bioscience, Novo Nordisk Enter Metabolic Research Pact

To explore Lumen's drug development and manufacturing platform to deliver oral biologics for cardiometabolic disease.

06.16.21

Tablet Development Process Training - July 20-21

This course provides comprehensive insight into the tablet development process to provide powerful tools that you can put to work immediately.

Breaking News | Industry News

GENinCode, EVERSANA Enter Major U.S. Commercialization Pact

EVERSANA will support launch and commercialization in the U.S. market for GENinCode’s portfolio of polygenic cardiovascular disease products.

06.14.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

ProCell for Patient Project to Develop Automated Production Unit for CAR-T Cell Therapies

Standardized and automated manufacturing aims to reduce the amount of work on producing CAR-T cells by 50 percent.

06.10.21

Portonbio Enters CAR-T Partnership with KAEDI

CDMO will provide KAEDI with CMC services for multiple projects.

Tim Wright, Editor, Contract Pharma 06.07.21

Bio News | Breaking News | cGMP Manufacture | Facilities | Industry News

Fusion to Build Radiopharma Manufacturing Facility

New 27,000 square foot site will be operational by 2024.

Tim Wright, Editor, Contract Pharma 06.07.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

VIVEbiotech Launches Lentiviral Vectors Mfg. Plant

Increases production capacity by 400% to deliver commercial-size batches for Cell and Gene Therapy Sector.

Kristin Brooks 06.04.21

Clinical Trials | CRO News | Drug Development | Information Technology

Driving Efficiencies in Today’s Complex Trials

Murray Aitken of IQVIA discusses CRO market trends, post-pandemic opportunities, and leveraging tech-enabled services and capabilities.

Kristin Brooks, Managing Editor, Contract Pharma 06.03.21

Bio News | Breaking News | Collaborations & Alliances | Industry News

Samsung Biologics Signs Agreement with Kahr Medical

Will support Kahr’s drug candidate DSP502, a TIGITxPD1 fusion protein.

Charles Sternberg, Assistant Editor 06.03.21

Clinical Trials | Drug Development

The Future is Decentralized: What This Means for Clinical Trial Sites

Benefits for research sites and how to prepare for decentralized trials.

Marc Leighton, Vice President of Product at Florence Healthcare 06.02.21

Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines

The Future of Continuous Bioprocessing

The modernization of advanced therapy manufacturing.

Dr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 06.02.21

Breaking News | Collaborations & Alliances

Aptamer Group Collaborates with PinotBio

Will work together to develop new therapeutic drug conjugates.

Charles Sternberg, Assistant Editor 06.02.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

CCRM Enters Regenerative Medicine Partnerships

Signs agreements with Canadian and international institutions to advance regenerative medicine inventions.

Tim Wright, Editor, Contract Pharma 06.01.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Thibault Jonckheere Named CEO of Exothera

The viral vector CDMO spinoff of Univercells is making an intranasal vaccine candidate for Covid-19 treatment.

Tim Wright, Editor, Contract Pharma 06.01.21

Bioanalytical Services | Biologics, Proteins, Vaccines

The Future of Continuous Bioprocessing

The Modernization of Advanced Therapy Manufacturing

Dr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 05.27.21

Breaking News | Collaborations & Alliances | Industry News

Hovione and iBET Form Strategic Collaboration

Will combine knowledge from both partners to create innovation in new therapeutic fields.

Tim Wright, Editor, Contract Pharma 05.27.21

Bio News | Breaking News | Industry News

August Bioservices Expands U.S. Biopharma Manufacturing Capabilities

$23.6 million investment from Polaris Partners will expand manufacturing capacity and capabilities to support production of sterile injectables.

Tim Wright, Editor, Contract Pharma 05.27.21

Bio News | Breaking News | Collaborations & Alliances | Industry News

The Discovery Labs Signs Lease with UPenn's Gene Therapy Program

The University will use Discovery Labs’ campus for a portion of its research operations focused on the development of genetic medicines.

Charles Sternberg, Assistant Editor 05.27.21

Biologics, Proteins, Vaccines | Breaking News

Dyadic Collaborates with Syngene to Develop Covid-19 Vaccine Candidate

Will develop a candidate to immunize people against current and future variants.

Charles Sternberg, Assistant Editor 05.26.21

Biologics, Proteins, Vaccines | Clinical Trials | Drug Development

Gene Therapy Trials

Critical regulatory and study start-up questions for gene therapy trials in the U.S., UK, and Europe.

April Marquick, Cell and Gene Therapy Expert, Premier Research 05.26.21

Clinical Trials | Drug Development | Information Technology

Clinical Development Trends

Digital modernization, decentralized trials, and advanced therapies drive outsourcing of clinical trials.

Kristin Brooks, Managing Editor, Contract Pharma 05.25.21

Breaking News | Promotions & Moves

Sterling Pharma Appoints Stewart Mitchell as New Site Head

Will lead new antibody-drug conjugate (ADC) facility in Deeside, UK.

Kristin Brooks 05.24.21

Breaking News | CRO News | Industry News

Premier Research Acquires Camargo Pharmaceutical Services

Expands product planning, development and differentiation services offered.

Tim Wright, Editor, Contract Pharma 05.21.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development

Thermo Fisher, UCSF to Open Cell Therapy cGMP Mfg. Center

Thermo Fisher will build and operate a 44,000-sq.-ft. cell therapy development, manufacturing and collaboration center on UCSF's Mission Bay campus.

Kristin Brooks 05.20.21

Breaking News | Industry News

ACG Wins iF Award for ‘Karton X’

Karton X is a high-speed cartoner with an output of 300 items per minute.

Charles Sternberg, Assistant Editor 05.19.21

Breaking News | Collaborations & Alliances | Industry News

Univercells Technologies Collaborates with NIBRT

Adds scale-X carbo integrated system at Dublin facility for intensified upstream viral manufacturing demonstrations and training.

Charles Sternberg, Assistant Editor 05.19.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News

Gamma Biosciences Acquires Stake in Mirus Bio

Supports Mirus’ expansion of GMP production of its flagship product TransIT VirusGEN for large scale manufacturing of AAV and LV viral vectors for gene therapy.

Kristin Brooks 05.18.21

Breaking News | Promotions & Moves

BioNTech SE Appoints Jens Holstein as CFO

Holstein succeeds Dr. Sierk Poetting.

Charles Sternberg, Assistant Editor 05.18.21

R&D Alliance for Eye Disease Cell Therapies

BlueRock Therapeutics, Fujifilm Cellular Dynamics, and Opsis Therapeutics enter R&D pact to discover and develop cell therapies for eye diseases.

Tim Wright, Editor, Contract Pharma 05.17.21

BioMedX Extends Collaboration with Merck

Merck will support up to six more research groups at the BioMed X Institute in Heidelberg within the next six years.

Charles Sternberg, Assistant Editor 05.17.21

Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Industry News

PerkinElmer Acquires Nexcelom Bioscience

Bolsters preclinical portfolio and enhances QA/QC capabilities in cell and gene therapy and biologics manufacturing.

Tim Wright, Editor, Contract Pharma 05.17.21

Breaking News | Industry News | Promotions & Moves

Matica Biotech Names Dr. Yun Jeong Song as CEO

Song's background spans more than 20 years of basic research, patient care and biopharmaceutical industry leadership.

Charles Sternberg, Assistant Editor 05.13.21

Breaking News | Promotions & Moves

New Amsterdam Sciences Appoints Executive Vice President

Dr. Christopher van de Wetering brings decades of governmental experience.

Charles Sternberg, Assistant Editor 05.12.21

Breaking News | Industry News

HBC, Catalent Enter Innovative Softgel Alliance

Partnership will leverage Catalent’s OptiGel DR technology to develop a delayed-release formulation of HBC’s OmeGo fish oil.

Kristin Brooks 05.12.21

Breaking News | Clinical Trials | CRO News

Emmes Acquires Orphan Reach

Establishes Emmes as an industry leader in clinical research for orphan and rare diseases.

Kristin Brooks 05.12.21

Bio News | Breaking News | Facilities

NJ Bio Moves Headquarters to Princeton, New Jersey

The 35,000-square-foot site was formerly occupied by Bristol Myers Squibb.

Tim Wright, Editor, Contract Pharma 05.11.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development

IDRI, Duke Vax Institute, 3M Partner on Adjuvant COVID Vax

Studies show 3M-052/Alum formulation elicits a strong, durable immune response against several strains of coronavirus, including bat coronaviruses.

Kristin Brooks 05.10.21

Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News

3P and Buzzard Pharmaceuticals Enter Cancer Collaboration

Enter into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra.

Charles Sternberg, Assistant Editor 05.07.21

APIs | Breaking News | Collaborations & Alliances | Cytotoxics and High Potency Manufacturing | Industry News

FDA Approves ADC Therapeutics' Zynlonta

ADC collaborated with CDMO Sterling Pharma Solutions to develop the cancer drug.

Tim Wright, Editor, Contract Pharma 05.07.21

Breaking News | Collaborations & Alliances | Industry News | Packaging & Tracking | Serialization

Yangtze River Pharmaceutical Group Selects TraceLink Solution to Aid Growth

Will use TraceLink’s applications and digital supply network to comply with track and trace requirements in multiple markets.

Charles Sternberg, Assistant Editor 05.07.21

Breaking News | Drug Development | R&D

Crown Bioscience Acquires OcellO

Expands its portfolio of in vitro services.

Charles Sternberg, Assistant Editor 05.06.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances

ADC Therapeutics Receives FDA Approval for Zynlonta

ADC collaborated with Sterling Pharma Solutions to develop Zynlonta.

Charles Sternberg, Assistant Editor 05.06.21

Breaking News | Drug Delivery | Drug Development | Industry News

Vectura, Inspira Partner to Develop Inhaled COVID Treatment

Further testing and development work to prepare for Phase 1 studies using its FOX vibrating mesh nebulizer to deliver IPX formulations.

Kristin Brooks, Contract Pharma 05.06.21

Are Your Suppliers Supporting Your Growth?

The role of strategic sourcing and procurement for emerging biopharmaceutical companies.

Dave Stowe and Jonathan Horn, Tunnell Consulting 05.05.21

Breaking News | cGMP Manufacture | Industry News | Information Technology

Autolomous to Expedite Digitization of Batch Verification

Will work to develop AutoloMATE-Assist, a digital batch verification technology for cell and gene therapies to alleviate paper based bottlenecks.

Kristin Brooks 05.04.21

Albumedix Extends Research Collaboration with Cobra Biologics

Collaboration investigates enhanced manufacturing of AAV and lentiviral vectors to improve quality and productivity for gene therapy and vaccine developers.

Tim Wright, Editor, Contract Pharma 05.03.21

CCRM and Amgen Partner to Advance Emerging Medical Innovations

New fund to support regenerative medicine discoveries with high potential impact for patients.

Tim Wright, Editor, Contract Pharma 05.03.21

AMRI Adds R&D and Mfg. Solutions for Orphan Products

Targeted investments globally expand scale and compound handling capabilities at facilities in Albany, Grafton, and Glasgow.

Kristin Brooks 04.30.21

Formulation Development

Melt Extrusion and How Helps Advance New Medicines

Bernd Liepold, Ph.D. of AbbVie explains melt extrusion and how it works in the formulation of new medicines.

Breaking News | Industry News | Promotions & Moves

Frontage Laboratories Appoints Executive Director, Regional Head of Sales, West

John Foster will be accountable for overseeing business development efforts in the western US.

Charles Sternberg, Assistant Editor 04.29.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

GenScript Launches Research Lentiviral Vector Packaging Service

Enables scientists to package their genetic material of choice to ensure consistent production of functional and intact viruses.

Charles Sternberg, Assistant Editor 04.29.21

PPD to Expand GMP Lab in Ireland

Adding cell and gene therapy capabilities to support growing customer need.

Tim Wright, Editor, Contract Pharma 04.29.21

Breaking News | Cold Chain Management | Collaborations & Alliances | Industry News | Packaging & Tracking

Catalent and Stirling Ultracold Enter Cold Chain Partnership

To establish energy-efficient cold chain capabilities for biologics and emerging modalities.

Tim Wright, Editor, Contract Pharma 04.29.21

Biologics, Proteins, Vaccines | Breaking News

Introducing ViroCell Biologics

The UK’s first clinical trial focused viral vector manufacturer.

Charles Sternberg, Assistant Editor 04.28.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax

Looks to secure a supply agreement for the only inactivated vaccine candidate in clinical trials against COVID-19 in EU.

Kristin Brooks 04.22.21

Clinical Trials | CRO News | Information Technology

Syneos, Medable Partner for New Decentralized Capabilities

Aims to increase clinical trial diversity and improve patient access and experiences with fit-for-purpose decentralized digital solution.

Kristin Brooks 04.22.21

Breaking News | Collaborations & Alliances | Industry News

Kintor, Visum Enter COVID-19 Manufacturing Partnership

To expand proxalutamide manufacturing for treatment of COVID-19 patients.

Tim Wright, Editor, Contract Pharma 04.19.21

Breaking News | Drug Development | Industry News

Evotec Enters Master Service Agreement with Kazia Therapeutics

Will work together to make EVT801 available to patients globally.

Charles Sternberg, Assistant Editor 04.19.21

Breaking News | Drug Development | Industry News

Bristol Myers Squibb Expands at Cambridge Crossing

Adds remaining 113,000 square feet to its initial lease at 250 Water Street.

Kristin Brooks 04.16.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Abenza Chooses North Carolina for New Biologics Manufacturing Site

GMP manufacturing will commence in mid-2022.

Charles Sternberg, Assistant Editor 04.15.21

Breaking News | CRO News | Industry News

Thermo Fisher Acquires PPD for $17.4B

Further expands service offering to pharma and biotech customers.

Tim Wright, Editor, Contract Pharma 04.15.21

Breaking News | Industry News | Information Technology

Arkema Recruits Dotmatics as its R&D Digitalization Partner

Agreement supports Arkema’s project to modernize access to R&D data and reduce design times for new products.

Charles Sternberg, Assistant Editor 04.15.21

Breaking News | Drug Development | Industry News

BioVersys Gets EIB Funds to Address Antimicrobial Resistance

Financing supports development of BioVersys’ breakthrough hospital antibiotic therapy targeting Acinetobacter baumannii

Kristin Brooks 04.14.21

Breaking News | Industry News | Microbiology

Microbiologics Expands Virology Services

Increases capabilities and capacity to provide anti-infective testing, assay development and biomaterial production services for highly infectious pathogens.

Kristin Brooks 04.14.21

Breaking News | Promotions & Moves

Executive Moves: Novavax

Gale Smith named SVP, Discovery and Pre-Clinical Research and Chief Scientist, and Troy Morgan named SVP, Chief Compliance Officer.

Kristin Brooks 04.14.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Sanofi Acquires Tidal Therapeutics

Gains novel mRNA-based technology with research capabilities in immuno-oncology and inflammatory diseases, with potential in other disease areas.

Kristin Brooks 04.12.21

Breaking News | Clinical Trials | CRO News | Industry News

Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

Offers full-service human absorption, metabolism, and excretion (hAME) studies with radiolabeled compounds.

Tim Wright, Editor, Contract Pharma 04.09.21

Analytical Services | Bioanalytical Services | Breaking News | Industry News

Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

Specializes in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarker and immunological pharmacodynamics assessments.

Kristin Brooks 04.08.21

Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals

Supporting R&D optimization of next-generation biopharmaceuticals with digital technology and drug discovery platform.

Tim Wright, Editor, Contract Pharma 04.07.21

Breaking News | Clinical Trials | CRO News | Drug Development

Moleculin Selects IQVIA Biotech to Advance COVID Treatment

IQVIA to manage the company's effort to begin potential clinical trials of WP1122 for the treatment of COVID-19.

Kristin Brooks 04.06.21

Sanofi to Build New $700M Flu Vaccine Facility in Canada

Facility will be located in Toronto and will increase supply of influenza vaccines in Canada, the U.S. and Europe.

Tim Wright, Editor, Contract Pharma 04.05.21

Breaking News | Industry News | Information Technology

LabVantage Solutions Expands and Improves its Portfolio

Unveils two new solutions and an updated version of its flagship LIMS platform.

Charles Sternberg, Assistant Editor 04.05.21

Breaking News | Excipients | Facilities | Industry News

Crystec Launches New R&D Center in China

New site in Haimen, Jiangsu province has been established following an invitation to participate in the Yangtze Delta Advanced Drug Development platform.

Tim Wright, Editor, Contract Pharma 04.05.21

Bioanalytical Services | Breaking News | CRO News | Industry News

Charles River Acquires Retrogenix

Strengthens scientific expertise with the addition of cell microarray technology and off-target profiling for drug discovery.

Tim Wright, Editor, Contract Pharma 04.05.21

Clinical Trials | Drug Development | QA/QC

RBQM Comes of Age: COVID as a Catalyst for Change

Clinical trial conduct has undergone a fundamental shift over the last year – and things will never be the same again.

Kristin Brooks, Managing Editor 04.01.21

Breaking News | Drug Development

Servier Acquires Agios Pharmaceuticals’ Oncology Portfolio

Expands its oncology leadership capabilities in the U.S.

Charles Sternberg, Assistant Editor 04.01.21

Enteris BioPharma: Custom Solutions – From Bench to Market

CDMO operations are housed within a 32,000-square-foot, FDA-inspected and cGMP-compliant facility in northern New Jersey.

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Ajinomoto, Bright Peak Enter Immunocytokines Research Pact

Exclusive license agreement to incorporate Ajinomoto Co.’s AJICAP site-specific bioconjugation technology for the development of Bright Peak Immunocytokines.

Kristin Brooks 03.30.21

Breaking News | cGMP Manufacture | Collaborations & Alliances

BioCentriq, Kytopen Enter Cell Therapy Alliance

Demonstrates the impact of transformative technology on cell therapy manufacturing.

Charles Sternberg, Assistant Editor 03.24.21

Breaking News | R&D

JSR Life Sciences Unveils Corporate Venture Fund

Aims to foster investment in new companies and innovative technologies.

Charles Sternberg, Assistant Editor 03.24.21

Clinical Trials | CRO News | Information Technology

PPD, Clinical Ink Partner on Near Real-Time Access to Endpoint Data

Jointly develop systemic lupus erythematosus assessment review process to enhance data quality and research site personnel experiences and efficiencies.

Kristin Brooks 03.24.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

BioCentriq and Kytopen Enter Cell Therapy Partnership

To show the impact to autologous and allogeneic cell therapies by integrating novel transfection technology with other steps in the manufacturing process.

Tim Wright, Editor, Contract Pharma 03.23.21

Breaking News | Facilities | Industry News

Raybow Pharmaceutical Expands in U.S.

China-based CDMO will invest $15.8 million in North Carolina facility.

Tim Wright, Editor, Contract Pharma 03.23.21

Breaking News | Collaborations & Alliances

Thermo Fischer Scientific Collaborates with Protein Metrics

Will facilitate precise, reliable mass spectrometry data processing and drive innovation for biopharmaceutical and proteomics applications.

Charles Sternberg, Assistant Editor 03.22.21

Breaking News | Drug Development | Facilities | Industry News | Parenterals

Eisai Begins Construction of New Injection/Research Building

To accommodate expanded drug discovery targets and new modalities such as antibodies, ADCs, and nucleic acid drugs.

Kristin Brooks 03.22.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

Evotec, Takeda Enter Multi-RNA Target Alliance

To discover and develop small molecule therapeutics for highly attractive targets that are difficult to address via more conventional approaches.

Kristin Brooks 03.22.21

Bio News | Breaking News | Collaborations & Alliances | Industry News

Fujifilm and Sana Biotechnology Enter Cell Therapy Partnership

Enter license agreement for the development of iPSC-derived cell therapies.

Tim Wright, Editor, Contract Pharma 03.17.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Selexis, Pandion Enter Antibody Service Agreement

Pandion will leverage Selexis’ SUREtechnology Platform to advance an antibody targeting autoimmune and inflammatory diseases.

Kristin Brooks 03.16.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine

Will make manufacturing capacity available at IDT’s facilities in Germany to manufacture the single-shot COVID-19 vaccine.

Tim Wright, Editor, Contract Pharma 03.15.21

Clinical Trials | Information Technology

The Evolution of Clinical Research Technology to Support Remote Collaboration

Pioneering change with technology advancements that yield high reward with tolerable risk.

Angela Gill Nelms, COO for Florence Healthcare 03.11.21

Breaking News | Collaborations & Alliances | Drug Development

Selexis SA and BITT Enter Service Agreement

Will develop the cell line for BITR2101, BITT’s lead tumor necrosis factor receptor 2 oncology candidate.

Charles Sternberg, Assistant Editor 03.10.21

cGMP Manufacture | Process Development | Scale-up/Technology Transfer

Process Intensification: Understanding the Optimal Way to Maximize Productivity

Overcoming challenges of implementation and achieving increased volume, reduced timelines, decreased footprint, lower cost of goods, and increased flexibility.

Priyanka Gupta, Head of Market Entry Strategy for Protein Based Therapeutics, Sartorius 03.09.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Celonic to Boost Cell & Gene Therapy Production

Will establish a new facility in the upcoming Life Science Park Rheintal in Stein, Switzerland.

Tim Wright, Editor, Contract Pharma 03.05.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

Continues to build integrated capabilities platform for cell and gene therapy.

Tim Wright, Editor, Contract Pharma 03.05.21

Breaking News | Collaborations & Alliances | Drug Delivery | Industry News

Aptamer Extends Collaboration with AstraZeneca

Will continue to explore next-generation drug delivery approaches.

Tim Wright, Editor, Contract Pharma 03.05.21

Information Technology

5 Reasons Paper Has No Place in Contract Manufacturing

Digital solutions create more efficient manufacturing processes and eliminate delays.

Dave Edwards, Chief Revenue Officer, MasterControl 03.01.21

Cold Chain Management | Logistics | Packaging & Tracking | Supply Chain

Reshaping the Pharmaceutical Supply Chain

The pandemic and COVID-19 vaccines bring navigating the cold-chain and preserving precious biologics to the forefront.

Kristin Brooks, Managing Editor 03.01.21

Breaking News | CRO News | Drug Discovery | Industry News | R&D

Icon to Acquire PRA Health Sciences

Brings together two organizations to create a leading healthcare intelligence and clinical CRO.

Charles Sternberg, Assistant Editor 03.01.21

Breaking News | Collaborations & Alliances | Industry News

Phlow Corp. and USP Form Alliance

Focused on continuous manufacturing to increase supply of essential medicines for U.S. patients.

Tim Wright, Editor, Contract Pharma 03.01.21

Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments

Novo Nordisk Invests $80M in Tablet Production

Expanding site in Måløv, Denmark that currently makes oral products to treat diabetes.

Tim Wright, Editor, Contract Pharma 03.01.21

Breaking News | Promotions & Moves

Spark Therapeutics Appoints CTO

Cynthia Pussinen will oversee manufacturing and technical operations, including pipeline process development, preclinical and clinical manufacturing.

Kristin Brooks 02.26.21

Bio News | Breaking News | Industry News

High Purity New England Bolsters Biopharma Solutions Services

Launches customizable cell culture bioreactor line.

Tim Wright, Editor, Contract Pharma 02.25.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

AMRI Contributes to Efforts to Increase COVID-19 Vax Supply

Joins network of approved manufacturers of lipid excipients for Pfizer-BioNTech COVID-19 vaccine.

Tim Wright, Editor, Contract Pharma 02.25.21

CatSci Opens New Site in UK

Strengthens analytical capabilities with the opening of a secondary site in Dagenham backed by a $4.2 million investment.

Tim Wright, Editor, Contract Pharma 02.25.21

Breaking News | Collaborations & Alliances | Drug Development | Industry News | Solid Dosage/Creams/Ointments

Pfizer Partners with Medicines Manufacturing Innovation Center

To transform the formulation of oral solid dosage medicines.

Tim Wright, Editor, Contract Pharma 02.25.21

Bioanalytical Services | Breaking News | Industry News | Preclinical Outsourcing

Altasciences Contributes to Vibegron Approval

Provided clinical support for two drug-drug interaction studies and a bioavailability trial for the overactive bladder treatment.

Kristin Brooks 02.24.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Information Technology

Pfizer Selects Seven Bridges to Support RNA Sequencing Data

Seven Bridges will centralize and manage terabytes scRNASeq data, which provides detailed analysis of gene expression in individual cells.

Kristin Brooks 02.24.21

Analytical Services | Breaking News | Facilities | Industry News | Laboratory Testing

ACG Launches ACG Laboratories

Opens a process development lab in Shirwal, India.

Tim Wright, Editor, Contract Pharma 02.23.21

Catalent Acquires Delphi Genetics

Launches US plasmid manufacturing site to establish global pDNA development and manufacturing capabilities.

Tim Wright, Editor, Contract Pharma 02.23.21

Almac Group Completes $7M R&D Center

Significant expansion of biocatalysis, flow chemistry, and peptide capacity.

Tim Wright, Editor, Contract Pharma 02.23.21

Breaking News | Drug Development | Promotions & Moves

Aevitas Therapeutics Appoints President and CEO

Dr. Markus Peters offers a 25-year track record of developing and commercializing orphan and specialty pharmaceuticals.

Charles Sternberg, Assistant Editor 02.22.21

Breaking News | CRO News | Industry News

Eurofins Scientific Acquires Beacon Discovery

Expands its integrated drug discovery capabilities and expertise.

Charles Sternberg, Assistant Editor 02.19.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Intravacc Unveils New Pilot Vaccine Production Facility

State-of-the-art pilot plant for production of vaccine candidates in clinical phase I & II research.

Tim Wright, Editor, Contract Pharma 02.19.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Century Therapeutics Significantly Expands Capabilities

Unveils new operational, laboratory and manufacturing facilities in Pennsylvania and New Jersey.

Tim Wright, Editor, Contract Pharma 02.19.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Charles River Acquires CDMO Cognate BioServices

Pays roughly $875 million to significantly expand capabilities in the cell and gene therapy sector.

Tim Wright, Editor, Contract Pharma 02.17.21

Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development

Molecular Templates, BMS Enter Strategic Research Pact

Aims to discover and develop multiple therapies for specific oncology targets utilizing MTEM’s next-gen engineered toxin body (ETB) platform.

Kristin Brooks 02.11.21

Breaking News | Facilities | Industry News

Scapa Healthcare Enhances OTC Drug Manufacturing Capabilities

Makes multimillion dollar investment at its Knoxville facility.

Tim Wright, Editor, Contract Pharma 02.10.21

AbbVie, Caribou Ink CAR-T Collaboration

Leverages Caribou's next-generation CRISPR genome editing technology platform and AbbVie's antigen-specific binders.

Tim Wright, Editor, Contract Pharma 02.10.21

Jubilant Biosys, Yale Form Research Alliance

Aims to accelerate small molecule discovery programs leveraging Jubilant's medicinal chemistry, structural biology, in-vitro and in-vivo pharmacology.

02.10.21

Promotions & Moves

Lilly Apoints SVP, CFO

Anat Ashkenazi replaces Josh Smiley, who has resigned and will be leaving the company.

Kristin Brooks 02.09.21

Biologics, Proteins, Vaccines | Breaking News

RotaChrom Technologies Partners with Cyclolab

Aims to develop a more efficient and cost-effective process to purify Remdesivir, a widely used treatment option for COVID-19.

Charles Sternberg, Assistant Editor 02.09.21

Breaking News | Industry News | Promotions & Moves

AMRI Makes Executive Move

Appoints Scott Waldman to lead corporate development.

Tim Wright, Editor, Contract Pharma 02.08.21

Breaking News | CRO News | Industry News

Anova Enterprises Acquires Corlexia Clinical Services

Adds further depth and experience to the Anova leadership team.

Charles Sternberg, Assistant Editor 02.08.21

Breaking News | Industry News

TCG Lifesciences Expands Footprint to the U.S.

Establishes CDMO subsidiary TCG GreenChem in New Jersey and Virginia.

Tim Wright, Editor, Contract Pharma 02.08.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Paragon Biosciences Expands Cell and Gene Therapy Platform

Launches CiRC Biosciences with an initial focus on developing eye disease treatments.

Tim Wright, Editor, Contract Pharma 02.08.21

Biologics, Proteins, Vaccines | Clinical Trials

Inside a COVID Vaccine Trial

Dr. Murphy of ICON, provider of clinical services to Pfizer/BioNTech’s COVID vaccine program, discusses what it takes to conduct a vaccine trial of this scale.

Kristin Brooks, Managing Editor 02.05.21

Biologics, Proteins, Vaccines | Breaking News | Industry News

CureVac, UK Partner on Vaccines Against SARS-CoV-2 Variants

Aims to mitigate the effects of the pandemic and help prepare against future SARS-CoV-2 outbreaks by working on multiple variant vaccines.

Kristin Brooks 02.05.21

Industry News

Sepha Launches Small Batch Contract Packaging Service

Aims to provide cost-effective, low volume runs of blister and medical device packs within short turnarounds.

Kristin Brooks 02.05.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings

J&J Submits EUA for Single-Shot Janssen COVID Vax Candidate

Plans to distribute vaccine to U.S. government immediately following authorization, and expects to supply 100 million doses in 1H21.

Kristin Brooks 02.05.21

Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development

The Future of Vaccines and Biologics

Dr. Linda Marbán of Capricor Therapeutics discusses the advances in responding to infectious diseases.

Kristin Brooks, Managing Editor, Contract Pharma 02.04.21

Breaking News | Clinical Trials | Drug Development | Industry News

Affimed, Roche Explore AFM24, Tecentriq Combo

To investigate the combination for the treatment of advanced solid epidermal growth factor receptor (EGFR) expressing malignancies.

Kristin Brooks 02.03.21

Breaking News | Collaborations & Alliances | Drug Development

Imcyse, Pfizer Enter Autoimmune Research Alliance

Will develop Imotope candidates to potentially treat Rheumatoid Arthritis.

Charles Sternberg, Assistant Editor 02.03.21

Immunome, Abzena Enter COVID-19 Antibody Cocktail Agreement

Abzena will work with Immunome to produce the antibody cocktail for clinical testing.

Kristin Brooks 02.03.21

Breaking News | Drug Development | Industry News

Lilly Acquires Asahi Kasei’s Chronic Pain Candidate

To pay $20 million upfront and up to $210 million in potential milestones for AK1780, an orally bioavailable P2X7 receptor antagonist.

Kristin Brooks 02.01.21

Breaking News | Drug Development | Industry News

Gilead, Gritstone Enter Vax Platform Pact for HIV Cure

Aims to develop HIV-specific vaccine using Gritstone’s prime-boost vaccine platform with antigens developed by Gilead.

Kristin Brooks 02.01.21

Cold Chain Management | Logistics | Supply Chain

Delivering Custom Client Solutions

Cold chain solutions provider Sentry BioPharma Services is able to adapt to meet the diverse needs of its clients.

Contract Pharma Staff

Evozyne, Takeda Ink Strategic Protein Design Agreement

Takeda will use Evozyne's evolution-based protein design technology to research and develop proteins for next-gen gene therapies.

Kristin Brooks 01.28.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Lonza Launches Cryopreserved Leukopaks

Customizable cryopreserved Leukopaks aim to provide greater flexibility in immunology and cell therapy research.

Kristin Brooks 01.28.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Valneva Begins COVID Vax Production to Optimize Potential Deliveries

Inactivated, adjuvanted COVID-19 vaccine candidate is in Phase 1/2 clinical development with initial results in April 2021.

Kristin Brooks 01.28.21

Parenterals

Parenteral Drug Delivery Trends

A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.

Kristin Brooks, Managing Editor, Contract Pharma 01.27.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development

Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies

Lilly expands BLAZE-4 trial to evaluate bamlanivimab with VIR-7831, two neutralizing antibodies that bind to different epitopes of the SARS-CoV-2 spike protein.

Kristin Brooks 01.27.21

Clinical Trials | Information Technology

The State of Clinical Trial Technology

Blake Adams of Florence discusses key report findings and the clinical trial software used to support Pfizer’s global COVID-19 vaccine study.

Kristin Brooks, Contract Pharma 01.26.21

Clinical Trials

The Future of Clinical Trials Series: Part II

Greater awareness will ensure diversity is no longer an afterthought and patients will be at the center of every aspect of clinical research.

Jena Daniels, Rasmus Hogreffe, Ingrid Oakley-Girvan, Dr. Michelle Longmire, Medable 01.26.21

Breaking News | Collaborations & Alliances

BioMed X, Janssen Enter Oral Drug Delivery Alliance

Aims to discover novel transport mechanisms which could be utilized for oral delivery of therapeutic modalities.

Charles Sternberg, Assistant Editor 01.26.21

Breaking News | Clinical Trials | Industry News

Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial

Care Access to provide decentralized, mobile research site operations for AstraZeneca’s AZD7442 Phase III trial in the U.S.

Kristin Brooks 01.26.21

Breaking News

500+ Sites Join Inato’s Industry Marketplace

Platform aims to make clinical research more inclusive and efficient.

Charles Sternberg, Assistant Editor 01.26.21

Breaking News | cGMP Manufacture | Excipients | Industry News

PromoCell Receives EXCiPACT Certification

Manufactures pharmaceutical excipients to GMP standards for tailor-made cell culture media and reagents that fulfill specific regulatory requirements.

Kristin Brooks 01.26.21

Breaking News | Facilities | Industry News | Injectables | Parenterals

Civica to Build an Essential Medicines Manufacturing Facility in Virginia

Will produce sterile injectable meds used in hospitals for COVID-19 patient care.

Tim Wright, Editor, Contract Pharma 01.25.21

Humanigen, Emergent Enter Covid-19 Partnership

Sign contract development and manufacturing agreement for Phase 3 COVID-19 therapeutic candidate lenzilumab.

Tim Wright, Editor, Contract Pharma 01.25.21

Breaking News | Promotions & Moves

Eisai Appoints Chief Clinical Officer of Oncology Biz

Dr. Richard Woodman has 18 years of pharmaceutical experience in several different functional areas at both large and small biotech organizations.

Contract Pharma Staff 01.20.21

Clinical Trials

The Future of Clinical Trials Series: Part I

What will 2021 have in store for an industry in flux?

Alison Holland, Head of Decentralized Trials, Medable, Maria Fotiu, Executive Vice President of Decentralized Solutions, Syneos Health 01.19.21

Intravacc Completes Project for Provention Bio’s Vax Candidate

Potentially the first preventive vaccine for coxsackievirus B, a risk factor associated with type 1 diabetes and celiac disease.

Contract Pharma Staff 01.19.21

Breaking News | Collaborations & Alliances | Drug Discovery

Metrion, LifeArc Extend Neuroscience Alliance

Collaboration extended for another 12 months after successfully progressing into late stage hit-to-lead optimization phase.

Contract Pharma Staff 01.18.21

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

Janssen, TenNor Enter NTM Research Pact

To leverage TenNor’s multitargeting drug conjugation platform to discover new therapies to treat nontuberculous mycobacteria diseases.

Contract Pharma Staff 01.18.21

Clinical Trials | Drug Development | Information Technology

Virtual Clinical Trials: The Future of Dermatology Studies

COVID-19 has created lasting impacts for clinical trials and a host of benefits have arisen from the adoption of virtual and hybrid models.

Sonja VanWye, RN, MSN, Director, Dermatology Strategy, IQVIA Biotech 01.15.21

Breaking News | Collaborations & Alliances | CRO News | Industry News

Bioclinica Partners with Ikcon Pharma

Will work together to deliver best-in-class e-clinical solutions to the pharma industry & sponsors.

Contract Pharma Staff 01.15.21

Breaking News | Clinical Trials | CRO News | Industry News

Frontage Bolsters Clinical Services Capabilities

Unveils plans to provide full service human radiolabeled absorption, metabolism, and excretion study capabilities.

Contract Pharma Staff 01.15.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Precision Medicine Group Acquires Project Farma

Adds Project Farma's unique expertise to Precision's suite of end-to-end cell and gene therapy capabilities to support development and commercialization.

Contract Pharma Staff 01.14.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

FUJIFILM Diosynth Biotechnologies will provide GMP contract process development and manufacturing services as part of its role in the new center.

Contract Pharma Staff 01.14.21

The Dedicated Center

Outsourcing answer to the innovation and ROI challenge in the Biopharmaceutical Industry.

Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | R&D

Almac Sciences Secures Support from Invest NI

Accelerates enzyme discovery program.

Contract Pharma Staff 01.13.21

Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

The CDMO pays $80 million for dry powder inhaler spray drying, capsule manufacturing and packaging operations in Boston area.

Contract Pharma Staff 01.13.21

Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News

Cyclolab and EpiPharma Form Joint Venture

Will develop and commercialize Peptide drug candidates for the treatment of debilitating CNS and Pulmonary diseases.

Contract Pharma Staff 01.11.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production

Texas A&M System contract designates the CDMO’s Texas facility for emergency federal use.

Contract Pharma Staff 01.11.21

Clinical Trials | CRO News

Caprion-HistoGeneX Acquires Clinical Logistics

Expands its support of clinical trials specimen logistics.

Contract Pharma Staff 01.08.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Laboratory Testing

Biohaven Acquires Remaining Stake in Kleo Pharmaceuticals

Enters exclusive license agreement with Yale University for a novel extracellular degrader technology licensed from Spiegel Lab.

Contract Pharma Staff 01.08.21

Promotions & Moves

Ionis Appoints Clinical Development EVP

Eugene Schneider will oversee clinical development of novel antisense medicines across all of Ionis' therapeutic franchises.

Contract Pharma Staff 01.08.21

The Changing R&D Landscape

Emerging Technology Needs and Value Proposition for Strategic Partnerships with Contract Development and Manufacturing Organizations (CDMOs)

APIs | Breaking News | cGMP Manufacture | Facilities | Industry News

AmbioPharm Opens New Shanghai Campus

Adds European executive team members working out of new Zurich office.

Contract Pharma Staff 01.07.21

Clinical Trials | Drug Development

The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs

Appropriate adaptive designs in early stages of development can accelerate timelines and reduce costs, and help focus on the most promising agents.

Jürgen Hummel, MSc, Senior Director, Statistical Science, PPD, and Lead of PPD’s Adaptive Design Working Group 01.07.21

Breaking News

Bioclinica Acquires Saliency

Integrates the company's advanced AI technology into its Imaging Platform.

Contract Pharma Staff 01.06.21

Breaking News | Clinical Trials | Promotions & Moves

Parexel Appoints Chief Patient Officer

Demonstrates the company’s commitment to elevating the patient perspective.

Contract Pharma Staff 01.06.21

Genezen Laboratories Receives Growth Equity Investment

Will fund the completion of the company’s lentiviral vector production facility.

Contract Pharma Staff 01.05.21

RTP Formulation & Sterile Fill-Finish Facility

...

Breaking News | Promotions & Moves

Natoli Engineering Appoints Northeast Service Technician

Hires Danny Yadram Chandarballi for the position.

Contract Pharma Staff 12.18.20

Abenza Promotes Kimball Hall to President

Hall also joins the Company Board.

Contract Pharma Staff 12.18.20

Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News

Thermo Fisher Expands Plasmid DNA Mfg. Capabilities

New 67,000-square-foot Carlsbad, CA cGMP site will accelerate commercialization of plasmid-based medicines and vaccines.

Contract Pharma Staff 12.17.20

Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News

Passage Bio Invests in Gene Therapy Manufacturing R&D Site

In combination with dedicated cGMP suite at Catalent, the new lab creates foundation for integrated AAV gene therapy manufacturing.

Contract Pharma Staff 12.17.20

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

Evotec, BMS Advance Targeted Protein Degradation Projects

The first two targets transition into drug discovery after completing a comprehensive target validation process.

Contract Pharma Staff 12.17.20

Bio News | Breaking News | Industry News | Promotions & Moves

Samsung Biologics Names John Rim as President and CEO

Prior to being named chief executive, Rim was executive vice president at the Korea-based CDMO for the past three years.

Contract Pharma Staff 12.16.20

Collaboration Creates Bio Hub in Northern UK

CDMO Fujifilm Diosynth Biotechnologies is part of Northern Bio-Accelerator Partnership.

Contract Pharma Staff 12.16.20

CDMO Cognate BioServices Teams Up with L7 Informatics

To implement L7|ESP for integrated manufacturing and lab operations.

Contract Pharma Staff 12.16.20

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

INOVIO to Develop dMAb COVID Treatments under DARPA Grant

$37.6 million grant will leverage AstraZeneca's monoclonal antibody and INOVIO's dMAb technologies in the fight against COVID-19.

Contract Pharma Staff 12.15.20

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Lilly to Acquire Prevail Therapeutics in $1B Deal

Adds a new drug discovery and development modality and creates a gene therapy program anchored by Prevail's portfolio of neuroscience assets.

Contract Pharma Staff 12.15.20

Breaking News | Industry News

AstraZeneca to Acquire Alexion in $39B Deal

Expands scientific presence in immunology by adding Alexion's innovative complement-technology platforms and strong pipeline, and top seller Soliris.

Contract Pharma Staff 12.14.20

Clinical Trials | Drug Development | Information Technology

Advancing Digital Endpoints in Clinical Trials

An end-to-end approach to managing wearable devices through clinical development.

Kristin Brooks, Contract Pharma 12.14.20

Clinical Trials | Information Technology

Life Sciences Strive for Greater Agility

Embracing real-time drug safety monitoring during and post COVID will continue to propel the industry forward.

Ronan Brown, SVP of Integrated Technology & Compliance, and Joe Rymsza, VP, Global PV & Regulatory Technology Solutions, IQVIA 12.14.20

Biologics, Proteins, Vaccines | Breaking News | Industry News

Boehringer to Acquire NBE-Therapeutics in €1.2B Transaction

Gains iADC platform and potential best-in-class antibody-drug conjugate (ADC) therapies for the treatment of solid tumors.

Contract Pharma Staff 12.10.20

Biologics, Proteins, Vaccines | Breaking News | Industry News

Initium Therapeutics Launches Antibody Development Platform

Expands its antibody drug pipeline using GenScript Bio’s Berkeley Lights Beacon platform.

Contract Pharma Staff 12.09.20

Breaking News | CRO News | Industry News | R&D

LINK Medical Acquires IRW Consulting AB

Strengthens its position in the Nordics while improving its offerings and capabilities.

Contract Pharma Staff 12.09.20

Breaking News | Industry News | R&D

Colorcon Ventures Invests in i20 Therapeutics

Will work together to accelerate i2O’s research and development efforts.

Contract Pharma Staff 12.07.20

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Lilly, UnitedHealth to Study Bamlanivimab in High-risk COVID-19

The study will identify and treat a large, diverse population of high-risk individuals for COVID-19 with bamlanivimab under real-world conditions.

Contract Pharma Staff 12.04.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Batavia Biosciences and KU Leuven Join Forces

Will accelerate the development of a highly promising Covid-19 vaccine candidate.

Contract Pharma Staff 12.03.20

Breaking News | Drug Development | Promotions & Moves

NeuBase Therapeutics Appoints Chief Scientific Officer

Dr. Curt Bradshaw brings decades of experience in successfully delivering genetic medicines to clinics.

Contract Pharma Staff 12.02.20

Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News

KBI Biopharma Expands U.S. Ops

Invests $150 million in commercial biologics manufacturing facility in RTP, NC.

Contract Pharma Staff 12.02.20

Embion, Asahi Group Enter Strategic Collaboration

Plan to develop new products from brewing by-products generated by Asahi Group.

Contract Pharma Staff 12.01.20

CDMO Stelis Continues Expansion

Starts next phase of investment into its biologics manufacturing facility.

Contract Pharma Staff 12.01.20

Breaking News | Drug Development | Formulation Development | Industry News

Vectura, Kinaset Partner to Develop Asthma Treatment

Licenses VR588 to Kinaset, Vectura will provide formulation development services to support Phase I studies and ultimately commercialization.

Contract Pharma Staff 11.30.20

Breaking News | Clinical Trials | Industry News

SGS Initiates U.S. COVID-19 Clinical Trials

Phase 2/3 trial will examine the safety, tolerability, and efficacy of Sarconeos (BIO101) to treat COVID-19 related respiratory failure.

Contract Pharma Staff 11.30.20

Life Science Success Podcast: Matt Hicks

...

Breaking News | Facilities | Industry News | Injectables | Parenterals

ApiJect Systems Approved for $590 Million Loan

Supports building a U.S.-based facility with surge capacity to produce up to 3 billion single-dose prefilled plastic injectors per year.

Contract Pharma Staff 11.24.20

Breaking News | Facilities | Industry News

Abenza Upgrades Chemistry GMP Suites

Appoints new leadership at Bristol PA site.

Contract Pharma Staff 11.24.20

Breaking News | Clinical Trials | Industry News

Merck Acquires OncoImmune for $425M

Acquisition adds to Merck’s suite of clinical programs in response to SARS-CoV-2/COVID-19.

Contract Pharma Staff 11.24.20

Breaking News | Drug Development | Trials & Filings

Regeneron's COVID-19 Antibody Cocktail Gets EUA

Expects to have treatment doses ready for approximately 80,000 patients by the end of November, and 200,000 by the first week of January.

Contract Pharma Staff 11.23.20

Breaking News | Promotions & Moves

Summit Therapeutics Appoints Chief Operating Officer

Dr. Mahkam Zanganeh previously founded and led Maky Zanganeh and Associates consulting services firm.

Contract Pharma Staff 11.23.20

Breaking News | Collaborations & Alliances | Drug Development

Amgen Ends Cardio Alliance with Cytokinetics

Will transition the development and commercialization rights for omecamtiv mecarbil to Cytokinetics and Servier.

Contract Pharma Staff 11.23.20

Breaking News | Industry News | Promotions & Moves

Frontida BioPharma Appoints EVP Technology

Dr. Praful Agrawala brings years of pharmaceutical product development leadership experience to the company.

Contract Pharma Staff 11.20.20

Pfizer and BioNTech to Submit EUA for COVID-19 Vaccine

Expect to produce globally up to 50 million doses in 2020, up to 1.3 billion doses by the end of 2021; ready to distribute within hours after authorization.

Contract Pharma Staff 11.20.20

Collaborations & Alliances | Drug Development